Search Go
Follow Us:  linkedin twitter slideshare youtube google + pinterest
 
New Benchmarking Study: Creating High Impact Strategic Briefings for Pharmaceutical Company Leadership

CHAPEL HILL, N.C., Sept. 11, 2015 /PRNewswire/ -- One of the marks of a successful pharmaceutical company is how well it informs senior leadership about strategic opportunities and challenges in the marketplace.

With the velocity of business ever increasing, market intelligence and analytics leaders are regularly challenged to develop executive briefing templates that are clear, concise and impactful. One-page templates are a kind of "Holy Grail" for briefing senior leadership, operating committees and Boards of Directors.

Research and consulting leader Best Practices, LLC undertook a new study to probe what are the important elements to include and what are the best formats for two critical healthcare briefing templates:
  • The Competitive Landscape Summary Map
  • The Development Landscape Profile Map (often described as the Data Disclosure or Clinical Trials Progress Summary)

"Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizing Competitive Assessments & Data Disclosure Summaries" presents winning strategies and critical content elements for effectively informing senior leaders so they can make important decisions for a host of time-sensitive strategic issues.

Topics addressed in this research include:
  • How to craft a High-Impact Competitive Landscape Assessment Template
  • How to craft a High-Impact Clinical Development Assessment Template
  • Reporting Structures & Processes for Maximizing Competitive Assessment Impact

This study and report will provide market research and strategy leaders with a valuable blueprint for how to create and deliver effective and concise executive briefs.

Best Practices, LLC engaged 30 executives from 27 leading pharmaceutical, biotech, and life sciences companies for this research project. Twelve research participants represented large pharma organizations, while the remaining benchmark class emerged from mid-sized and smaller companies. Qualitative data was mined via deep-dive interviews with senior biopharma leaders.

To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1377.htm.

For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking and advisory services firm serving pharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and most of the top 50 pharmaceutical companies. The firm conducts primary research and uses its comprehensive benchmarking tools and executives interviews to form the basis for our Benchmarking Reports and advisory services utilized by top executives. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information